Learn about the Delaware Technology ParkLearn about Delaware Technology Park tenants.Technology communities at the Delaware Technology ParkFlexible space that meets your technological needsDelaware Technology Park newsDelaware Technology Park contact information
     
Delaware Technology Park Ñ Tenant Directory Delaware Technology Park Ñ Closed Resident Discussion Forums Delaware Technology Park Ñ Tenant News and Information

  Athena Biotechnologies Inc.
Barry L. Marrs, CEO

Athena Biotechnologies Inc.
Stine-Haskell Research Center
1090 Elkton Road
Newark, DE 19714

Tel: 302-224-3450x305
Fax: 302-224-3457

AthenaBio provides libraries of new bioactive molecules for screening by the pharmaceutical and agricultural chemical industries. These molecules are isolated from both plants and microbes through patented processes that focus on stimulating bioactive defense molecule production by living organisms. These processes yield new libraries in which each element can be reproducibly manufactured and scaled up. AthenaBio uses proprietary technology to culture new species of microbes, each of which is stimulated to yield new bioactive molecules. This revolutionary technology is also the key to AthenaBio''s upside potential: the cultivation of new microbes causing known diseases. We have a systematic approach to discovering the next new pathogen like Helicobacter pylori, the recently discovered causitive agent behind gastric ulcers.